Log In
BCIQ
Print this Print this
 

TT-601

  Manage Alerts
Collapse Summary General Information
Company Eli Lilly and Co.
DescriptionSmall molecule that binds an undisclosed nuclear receptor
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat osteoarthritis (OA) pain
Regulatory Designation
PartnerOpko Health Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$190.0M

0

$130.0M


 Deals Details
Get a free BioCentury trial today